- Home
- SOBR vs TCBP Comparison
SOBR vs TCBP Comparison
Compare SOBR & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOBR
- TCBP
- Stock Information
- Founded
- SOBR 2004
- TCBP 2013
- Country
- SOBR United States
- TCBP United Kingdom
- Employees
- SOBR 14
- TCBP N/A
- Industry
- SOBR Newspapers/Magazines
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOBR Consumer Discretionary
- TCBP Health Care
- Exchange
- SOBR Nasdaq
- TCBP Nasdaq
- Market Cap
- SOBR 561.4K
- TCBP 831.0K
- IPO Year
- SOBR N/A
- TCBP 2022
- Fundamental
- Price
- SOBR $0.61
- TCBP $1.69
- Analyst Decision
- SOBR
- TCBP Strong Buy
- Analyst Count
- SOBR 0
- TCBP 1
- Target Price
- SOBR N/A
- TCBP $48.00
- AVG Volume (30 Days)
- SOBR 5.6M
- TCBP 632.6K
- Earning Date
- SOBR 03-21-2025
- TCBP 11-25-2024
- Dividend Yield
- SOBR N/A
- TCBP N/A
- EPS Growth
- SOBR N/A
- TCBP N/A
- EPS
- SOBR N/A
- TCBP N/A
- Revenue
- SOBR $183,859.00
- TCBP N/A
- Revenue This Year
- SOBR $2,351.49
- TCBP N/A
- Revenue Next Year
- SOBR N/A
- TCBP N/A
- P/E Ratio
- SOBR N/A
- TCBP N/A
- Revenue Growth
- SOBR 27.39
- TCBP N/A
- 52 Week Low
- SOBR $0.40
- TCBP $1.43
- 52 Week High
- SOBR $88.00
- TCBP $523.20
- Technical
- Relative Strength Index (RSI)
- SOBR 37.61
- TCBP 28.01
- Support Level
- SOBR $0.56
- TCBP $1.43
- Resistance Level
- SOBR $0.81
- TCBP $2.19
- Average True Range (ATR)
- SOBR 0.16
- TCBP 0.28
- MACD
- SOBR 0.00
- TCBP 0.19
- Stochastic Oscillator
- SOBR 29.87
- TCBP 20.57
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending SOBRsafe software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.